通过机器学习改变神经退行性疾病护理:策略和应用
Aya Galal1, Ahmed Moustafa2, Mohamed Salama3
1Systems Genomics Laboratory, American University in Cairo, New Cairo, Egypt; Institute of Global Health and Human Ecology, American University in Cairo, New Cairo, Egypt.
Neuroscience
|March 22, 2025
概括
人工智能 (AI) 和机器学习 (ML) 为神经退行性疾病 (ND) 的早期诊断和个性化治疗提供了新的非侵入性工具. 本综述探讨了数据资源和ML应用程序,以推进神经退行性护理.
科学领域:
- 计算神经科学是一种神经科学.
- 医疗信息学 医疗信息学
- 神经学 神经学
背景情况:
- 神经退行性疾病 (NDs) 具有复杂的分子机制和多样化的患者症状,挑战依赖临床评估和神经成像的传统诊断.
- 目前的ND诊断方法往往缺乏早期检测能力和最终确认,经常需要进行尸检.
研究的目的:
- 作为对有兴趣将机器学习 (ML) 应用于神经退行性疾病 (NDs) 的研究人员的入门指南.
- 突出人工智能 (AI) 和ML在开发非侵入性诊断工具,识别生物标志物和个性化NDs治疗策略方面的变革潜力.
主要方法:
- 审查现有的文献和数据资源,相关的关键神经退行性疾病,如阿尔茨海默氏症和帕金森氏症.
- 探索适用于神经退行性疾病研究和临床实践的人工智能 (AI) 和机器学习 (ML) 方法.
- 重点是整合多个高维数据源以获得增强的洞察力.
主要成果:
- 人工智能和机器学习可以促进早期诊断,生物标志物发现,患者分层和神经退行性疾病风险预测.
- 该审查讨论了主要ND的数据资源的可用性,为ML应用提供了基础.
- 综合各种数据类型对于更深入的理解和有效的治疗开发至关重要.
结论:
- 机器学习 (ML) 对彻底改变神经退行性疾病 (ND) 的护理和管理具有重大前景.
- 整合多模式数据的进一步研究对于推进个性化医疗和改善NDs患者的治疗结果至关重要.
- 这一审查为利用ML在对抗神经退行性疾病的斗争中提供了一个起点.
相关概念视频
Alzheimer's Disease: Overview
405
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
405
Alzheimer's Disease: Treatment
139
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
139
Parkinson's Disease: Overview
405
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
405
Dementia
81
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
81


